On March 26, 2026, Cartesian Therapeutics, Inc. announced the resignation of Murat Kalayoglu, M.D., Ph.D., from its Board of Directors, effective March 31, 2026. Dr. Kalayoglu has been a member of the Board since 2023 and served as the Chairman of the Science and Technology Committee, as well as a member of the Nominating and Corporate Governance Committee. The company stated that his resignation was not due to any disagreements regarding the company's operations, policies, or practices. Cartesian Therapeutics expressed gratitude for Dr. Kalayoglu's contributions and leadership during his tenure. The company will now look to fill the vacancy left by Dr. Kalayoglu as it continues to advance its strategic initiatives in the biopharmaceutical sector.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.